0001231919-21-000020.txt : 20210219 0001231919-21-000020.hdr.sgml : 20210219 20210219162708 ACCESSION NUMBER: 0001231919-21-000020 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210219 DATE AS OF CHANGE: 20210219 EFFECTIVENESS DATE: 20210219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensoma, Inc. CENTRAL INDEX KEY: 0001846902 IRS NUMBER: 842970518 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389985 FILM NUMBER: 21656317 BUSINESS ADDRESS: STREET 1: 75 KNEELAND STREET, 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 BUSINESS PHONE: 617-766-3917 MAIL ADDRESS: STREET 1: 75 KNEELAND STREET, 14TH FLOOR CITY: BOSTON STATE: MA ZIP: 02111 D 1 primary_doc.xml X0708 D LIVE 0001846902 Ensoma, Inc. 75 KNEELAND STREET, 14TH FLOOR BOSTON MA MASSACHUSETTS 02111 617-766-3917 DELAWARE None None Corporation true 2019 Kush Parmar c/o Ensoma, Inc. 75 KNEELAND STREET, 14TH FLOOR Boston MA MASSACHUSETTS 02111 Executive Officer Director Paula Soteropoulos c/o Ensoma, Inc. 75 KNEELAND STREET, 14TH FLOOR Boston MA MASSACHUSETTS 02111 Director Albert Seymour c/o Ensoma, Inc. 75 KNEELAND STREET, 14TH FLOOR Boston MA MASSACHUSETTS 02111 Director Stephen Knight c/o Ensoma, Inc. 75 KNEELAND STREET, 14TH FLOOR Boston MA MASSACHUSETTS 02111 Director Biotechnology Decline to Disclose 06b false 2021-02-05 false true true false 0 70549902 40549910 29999992 The Total Offering Amount and The Total Amount Sold includes the conversion of $10,549,917.81 of outstanding convertible securities. false 11 0 0 0 false Ensoma, Inc. /s/Kush Parmar Kush Parmar Chief Executive Officer 2021-02-19